Home / What’s new?

News & publications

Stay updated on the most recent developments in MercachemSyncom



Latest news

MERCACHEMSYNCOM OPENS USA OFFICE IN CAMBRIDGE, MA

We are excited to tell you that this month we celebrated the opening of our first office in the USA at the Cambridge Innovation Center (CIC) at One Broadway, Cambridge, MA. The office will be managed by Dr. Bart DeCorte, Vice President of Business Development for North America.


Webinars


Latest patents

Inhibitors of vap-1

Number:
WO 2020/069330, WO 2020/069335

6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Number:
WO 2020/089455 A1

NOVEL UREA 6,7-DIHYDRO-4H-THIAZOLO[5,4-C]PYRIDINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Number:
WO 2020/089460 A1

Latest publications

Open Innovation and Pharma R&D Transformation: New Opportunities for Academic Research Institutions, Contract Research Organizations, and Biotech Companies

Article:
MEDCHEM NEWS Vol.30 No.1

Pre-clinical lead optimization of a 1,2,4-triazole based tankyrase inhibitor

Article:
J. Med. Chem., 2020, xxxx

The Evolving Outsourcing Landscape in Pharma R&D – Different Collaborative Models and Factors to Consider when Choosing a Contract Research Organization

Article:
J. Med. Chem., 2020, xxx

Scroll to top